[go: up one dir, main page]

MX2018009539A - Uso de comunidades microbianas para la salud humana y animal. - Google Patents

Uso de comunidades microbianas para la salud humana y animal.

Info

Publication number
MX2018009539A
MX2018009539A MX2018009539A MX2018009539A MX2018009539A MX 2018009539 A MX2018009539 A MX 2018009539A MX 2018009539 A MX2018009539 A MX 2018009539A MX 2018009539 A MX2018009539 A MX 2018009539A MX 2018009539 A MX2018009539 A MX 2018009539A
Authority
MX
Mexico
Prior art keywords
human
animal health
microbial communities
mixture
bacteria
Prior art date
Application number
MX2018009539A
Other languages
English (en)
Other versions
MX382399B (es
Inventor
Possemiers Sam
Marzorati Massimo
Van De Wiele Tom
Scheirlinck Ilse
Van Den Abeele Pieter
Bolca Selin
Gottardi Davide
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of MX2018009539A publication Critical patent/MX2018009539A/es
Publication of MX382399B publication Critical patent/MX382399B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/26—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
    • C12M41/34—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of gas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/513—Adolescentes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Sustainable Development (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una mezcla de bacterias que pertenecen a al menos 6 o 7 especies bacterianas diferentes y específicas preferiblemente, para usarlas para prevenir o tratar trastornos gastrointestinales. Preferiblemente, dicha mezcla de bacterias se cultivan juntas en un fermentador, antes de administrar la mezcla a un sujeto, con el fin de prevenir o tratar el trastorno.
MX2018009539A 2016-02-04 2017-02-03 Uso de comunidades microbianas para la salud humana y animal. MX382399B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16154288 2016-02-04
PCT/EP2017/052422 WO2017134240A1 (en) 2016-02-04 2017-02-03 Use of microbial communities for human and animal health

Publications (2)

Publication Number Publication Date
MX2018009539A true MX2018009539A (es) 2019-02-11
MX382399B MX382399B (es) 2025-03-13

Family

ID=55310719

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009539A MX382399B (es) 2016-02-04 2017-02-03 Uso de comunidades microbianas para la salud humana y animal.

Country Status (23)

Country Link
US (7) US11096971B2 (es)
EP (3) EP3639834B1 (es)
JP (3) JP7016112B2 (es)
KR (2) KR102816794B1 (es)
CN (2) CN116570631A (es)
AU (2) AU2017216285B2 (es)
CA (1) CA3011083A1 (es)
CY (1) CY1123954T1 (es)
DK (2) DK3411052T3 (es)
ES (2) ES2824536T3 (es)
FI (1) FI3639834T3 (es)
HR (1) HRP20231182T1 (es)
HU (2) HUE051114T2 (es)
IL (3) IL293486B2 (es)
LT (2) LT3411052T (es)
MX (1) MX382399B (es)
PL (2) PL3639834T3 (es)
PT (1) PT3639834T (es)
RS (2) RS60918B1 (es)
RU (1) RU2758387C2 (es)
SI (2) SI3639834T1 (es)
SM (1) SMT202000547T1 (es)
WO (1) WO2017134240A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
RS60918B1 (sr) 2016-02-04 2020-11-30 Univ Gent Upotreba mikrobnih zajednica za zdravlje ljudi i životinja
GB2557823A (en) 2016-03-04 2018-06-27 Univ California Microbial consortium and uses thereof
MX2019003447A (es) 2016-09-27 2019-08-29 Univ Texas Metodos para mejorar la terapia de bloqueo del punto de control inmune mediante la modulacion del microbioma.
WO2018145082A1 (en) * 2017-02-06 2018-08-09 New York University Methods and compositions for treating and diagnosing pancreatic cancers
CN107384828B (zh) * 2017-08-22 2020-06-16 中国农业科学院农产品加工研究所 阿克曼氏粘细菌培养基及其制备方法
AU2018326705A1 (en) 2017-08-30 2020-03-05 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
KR102250597B1 (ko) 2017-11-20 2021-05-11 경희대학교 산학협력단 신규 유산균 및 이의 용도
WO2019098810A2 (ko) * 2017-11-20 2019-05-23 경희대학교 산학협력단 신규 유산균 및 이의 용도
AU2019253714A1 (en) 2018-04-10 2020-11-26 Siolta Therapeutics, Inc. Microbial consortia
US20210177916A1 (en) * 2018-04-13 2021-06-17 Med-Life Discoveries Lp Long chain dicarboxylic fatty acid (lcdfa) producing microbes and uses thereof
CN112154202A (zh) * 2018-05-04 2020-12-29 4D制药研究有限公司 模拟肠道环境
WO2020018949A2 (en) * 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
US11859214B1 (en) 2018-08-17 2024-01-02 The Government Of The United States, As Represented By The Secretary Of The Army Automated system for simulating the human lower gastrointestinal tract
WO2020056298A1 (en) * 2018-09-13 2020-03-19 Assembly Biosciences, Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
WO2020079026A1 (en) * 2018-10-15 2020-04-23 Pharmabiome Ag A method of manufacturing a consortium of bacterial strains
AU2019374773B2 (en) * 2018-11-05 2025-10-16 Clostrabio Methods and compositions for treating infectious, autoimmune, and allergic disease
US20220080001A1 (en) * 2019-01-16 2022-03-17 Board Of Regents, The University Of Texas System Methods and compositions for treating immune checkpoint inhibitor associated colitis
CN115944654A (zh) 2019-07-19 2023-04-11 芬奇治疗控股有限责任公司 用于治疗胃肠道病症的方法及产品
CN110607262B (zh) * 2019-09-25 2022-03-25 君维安(武汉)生命科技有限公司 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用
CN110448577B (zh) * 2019-09-26 2023-06-23 青岛农业大学 一种溃疡性结肠炎修复益生菌微胶囊制剂
CA3153884A1 (en) 2019-10-07 2021-04-15 Nikole KIMES Therapeutic pharmaceutical compositions
EP4040991A4 (en) * 2019-10-09 2024-01-24 Mayo Foundation for Medical Education and Research TREATMENT OF GASTROINTESTINAL DISORDERS
GB201915144D0 (en) * 2019-10-18 2019-12-04 Multigerm Uk Entpr Ltd Method of promoting SCFA production by gut microbiota
CN110916192B (zh) * 2019-11-25 2021-04-13 垒途智能教科技术研究院江苏有限公司 一种具有防治儿童青少年自闭症的益生菌矿物粉及其应用
JP7796537B2 (ja) * 2019-12-13 2026-01-09 株式会社明治 心拍数低下用組成物
MX2022007796A (es) 2019-12-23 2023-01-24 Evonik Operations Gmbh Preparacion que comprende cepas probioticas para la degradacion del gluten.
CN111281895A (zh) * 2019-12-24 2020-06-16 顾青 用于治疗结肠炎的乳酸菌及其应用
CN111117925B (zh) * 2020-01-13 2021-05-25 浙江大学 Anaerostipes sp B2131菌及其在炎症性肠病中的应用
CN111413503A (zh) * 2020-03-28 2020-07-14 浙江大学 骨桥蛋白作为靶分子在调节高脂饮食引起的肥胖中的应用
CA3179561A1 (en) 2020-04-08 2021-10-14 Megmilk Snow Brand Co., Ltd. Composition for improving gut microbiota
EP4132550A4 (en) * 2020-04-08 2024-02-28 Psomagen, Inc. Composition and method for an antibiotic-inducing imbalance in microbiota
JP7663322B2 (ja) * 2020-04-08 2025-04-16 雪印メグミルク株式会社 ビフィズス菌増殖促進剤
KR102169794B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도
CA3188645A1 (en) * 2020-08-14 2022-02-17 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies
CN111938158B (zh) * 2020-08-18 2023-07-07 广东弘元普康医疗科技有限公司 一种防止肠道Akkermansia muciniphila菌丰度降低的组合物
CN112080445A (zh) * 2020-08-20 2020-12-15 浙江工商大学 植物乳杆菌zj316和在抑制幽门螺旋杆菌方面的应用
JP2022052715A (ja) * 2020-09-23 2022-04-04 雪印メグミルク株式会社 腸内細菌叢改善用組成物
GB202015687D0 (en) * 2020-10-02 2020-11-18 Microbiotica Ltd Therapeutic composition
CN113215020B (zh) * 2021-02-22 2022-06-17 中国科学院微生物研究所 罗氏菌mgb-2及其应用
CN113214976B (zh) * 2021-03-29 2023-04-14 中南大学 一种高效筛选嗜酸微生物的装置及其筛选方法
BE1029496B1 (fr) * 2021-08-19 2023-01-16 The Akkermansia Company Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention des troubles de la contractilité intestinale, en particulier des troubles de l'amplitude de la contractilité duodénale
WO2023039645A1 (en) * 2021-09-20 2023-03-23 Hudson Institute of Medical Research Biotherapeutic enterococcus isolates
CA3242616A1 (en) 2021-12-27 2025-02-26 Ghent University Microbial communities
CN114292781B (zh) * 2021-12-28 2023-08-01 中山大学 一种长双歧杆菌sysu-02及其应用
CN114304380A (zh) * 2022-01-13 2022-04-12 合肥河川生物医药科技有限公司 普拉梭菌在猪鸡上的应用
NL2032642B1 (en) * 2022-07-29 2024-02-06 Academisch Ziekenhuis Leiden Improvement of muscle mass and strength
WO2024049207A1 (ko) * 2022-08-31 2024-03-07 주식회사 바이오뱅크힐링 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN115737687A (zh) * 2022-10-16 2023-03-07 新疆医科大学第一附属医院 普拉梭菌在制备预防或/和治疗冠心病药物或/和保健品中的应用
CN116004440B (zh) * 2022-10-25 2025-06-13 深圳未知君生物科技有限公司 一株粘膜粘液乳杆菌及其在制备治疗癌症的药物中的应用
WO2024123891A1 (en) * 2022-12-07 2024-06-13 The University Of North Carolina At Chapel Hill Office Of Technology Commercialization Engineered microorganism compositions and applications thereof
WO2024249585A1 (en) * 2023-05-31 2024-12-05 The Regents Of The University Of California Compositions and methods for treating mental and metabolic disorders
CN116836880B (zh) * 2023-07-24 2023-11-28 中山大学 一种普氏梭杆菌及其应用
CN116925975B (zh) * 2023-08-18 2024-01-23 善恩康生物科技（苏州）有限公司 一种Akkermansia muciniphila及其产品和应用
WO2025100480A1 (ja) * 2023-11-08 2025-05-15 慶應義塾 組成物、飲食品、及び病原性細菌又は病原性真菌に起因する疾患の検査及び診断を補助する方法
WO2025183115A1 (ja) * 2024-02-28 2025-09-04 三菱ケミカル株式会社 乳酸産生菌及び酪酸産生菌を含む整腸用組成物
CN118421503B (zh) * 2024-04-12 2025-02-11 善恩康生物科技（苏州）有限公司 一株新型Akkermansia muciniphila及其应用
CN118489883A (zh) * 2024-05-10 2024-08-16 河北弗蒙特生物科技有限公司 嗜黏蛋白阿克曼氏菌发酵物及其制备方法与应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307026D0 (en) 2003-03-27 2003-04-30 Rowett Res Inst Bacterial supplement
US20080311097A1 (en) * 2005-09-28 2008-12-18 Nordisk Rebalance A/S Treatment of Ibd and Ibs Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors
CN101353633B (zh) * 2008-06-13 2011-12-28 浙江工商大学 Lactobacillus plantarum ZJ316、产生的抗菌肽及其制备与应用
GB0903016D0 (en) * 2009-02-23 2009-04-08 Univ Gent Method for alleviating intestinal problems and novel bacterial strains therefor
IN2012DN03632A (es) * 2009-11-12 2015-06-26 Nestec Sa
US8445226B2 (en) * 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US20120034198A1 (en) 2010-08-04 2012-02-09 Microbios, Inc. Carriers for storage and delivery of biologics
WO2012142605A1 (en) * 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
JP5916846B2 (ja) 2011-05-16 2016-05-11 オルガノバランス メディカル アーゲー 細菌性感冒に対する新規な乳酸菌及びそれを含有する組成物
WO2013037068A1 (en) 2011-09-14 2013-03-21 Queen's University At Kingston Method for treatment of disorders of the gastrointestinal system
GB201117313D0 (en) * 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN103082292B (zh) * 2011-11-02 2015-03-04 深圳华大基因研究院 罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用
WO2014075745A1 (en) 2012-11-19 2014-05-22 Université Catholique de Louvain Use of akkermansia for treating metabolic disorders
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP2953472A4 (en) 2012-11-23 2017-03-01 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2014121298A2 (en) * 2013-02-04 2014-08-07 Seres Health, Inc. Methods of populating a gastrointestinal tract
BR112015020819A2 (pt) * 2013-03-05 2017-07-18 Academisch Ziekenhuis Groningen uso de faecalibacterium prausnitzii htf-f (dsm 26943) para supressão de inflamação
JP2016519664A (ja) 2013-03-15 2016-07-07 セレス セラピューティクス インコーポレイテッド ネットワークを基にした微生物組成物及び方法
US10058576B2 (en) * 2013-10-03 2018-08-28 The Trustees Of The University Of Pennsylvania Compositions and methods comprising a defined microbiome and methods of use thereof
PL236218B1 (pl) 2013-11-13 2020-12-28 Inst Biotechnologii Surowic I Szczepionek Biomed Spolka Akcyjna Zastosowanie kompozycji probiotycznej
MX367109B (es) * 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
EP2944696A1 (en) * 2014-05-13 2015-11-18 Evonik Degussa GmbH Method of producing organic compounds
EP4529950A3 (en) * 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
EP3150562B1 (de) * 2015-10-01 2022-02-16 Heraeus Quarzglas GmbH & Co. KG Verwendung von optischem filtermaterial aus dotiertem quarzglas sowie das optische filtermaterial enthaltende uv-lampe
RS60918B1 (sr) * 2016-02-04 2020-11-30 Univ Gent Upotreba mikrobnih zajednica za zdravlje ljudi i životinja

Also Published As

Publication number Publication date
US20230028557A1 (en) 2023-01-26
RS64782B1 (sr) 2023-11-30
CN108712906B (zh) 2023-06-30
HRP20231182T1 (hr) 2024-01-05
US20210353694A1 (en) 2021-11-18
IL283594A (en) 2021-07-29
IL260337A (en) 2018-08-30
IL293486B1 (en) 2023-12-01
RU2758387C2 (ru) 2021-10-28
US11633440B2 (en) 2023-04-25
IL260337B (en) 2021-06-30
JP2022058615A (ja) 2022-04-12
SMT202000547T1 (it) 2020-11-10
RU2021130638A (ru) 2021-11-18
JP7016112B2 (ja) 2022-02-04
PL3411052T3 (pl) 2021-03-08
PT3639834T (pt) 2023-10-12
US20190015465A1 (en) 2019-01-17
HUE063584T2 (hu) 2024-01-28
JP7737657B2 (ja) 2025-09-11
CY1123954T1 (el) 2022-03-24
HK1257070A1 (zh) 2019-10-11
HUE051114T2 (hu) 2021-01-28
LT3411052T (lt) 2021-01-11
EP3411052B1 (en) 2020-07-08
AU2017216285B2 (en) 2023-10-05
RU2018131244A (ru) 2020-03-04
CA3011083A1 (en) 2017-08-10
US20220072071A1 (en) 2022-03-10
DK3639834T3 (da) 2023-10-09
US11096971B2 (en) 2021-08-24
KR20250079251A (ko) 2025-06-04
JP7460979B2 (ja) 2024-04-03
JP2024028833A (ja) 2024-03-05
SI3639834T1 (sl) 2024-02-29
US20220023357A1 (en) 2022-01-27
IL283594B (en) 2022-06-01
RS60918B1 (sr) 2020-11-30
AU2023248066A1 (en) 2023-11-02
EP4257194A3 (en) 2023-12-20
US11596658B2 (en) 2023-03-07
CN116570631A (zh) 2023-08-11
KR102816794B1 (ko) 2025-06-05
PL3639834T3 (pl) 2024-01-29
DK3411052T3 (da) 2020-10-12
IL293486A (en) 2022-08-01
EP4257194A2 (en) 2023-10-11
AU2023248066B2 (en) 2025-12-11
US11491196B2 (en) 2022-11-08
JP2019511563A (ja) 2019-04-25
EP3639834B1 (en) 2023-07-12
ES2824536T3 (es) 2021-05-12
MX382399B (es) 2025-03-13
WO2017134240A1 (en) 2017-08-10
IL293486B2 (en) 2024-04-01
DK3639834T5 (da) 2024-08-26
US20230045069A1 (en) 2023-02-09
LT3639834T (lt) 2023-11-10
RU2018131244A3 (es) 2020-06-18
US20220040245A1 (en) 2022-02-10
ES2960781T3 (es) 2024-03-06
CN108712906A (zh) 2018-10-26
US12458672B2 (en) 2025-11-04
EP3639834A1 (en) 2020-04-22
EP3411052A1 (en) 2018-12-12
KR20180127972A (ko) 2018-11-30
BR112018015097A2 (pt) 2018-12-26
SI3411052T1 (sl) 2021-01-29
AU2017216285A1 (en) 2018-07-26
FI3639834T3 (fi) 2023-09-27
EP3411052B8 (en) 2020-09-30

Similar Documents

Publication Publication Date Title
MX2018009539A (es) Uso de comunidades microbianas para la salud humana y animal.
BR112013027609A2 (pt) bactérias bacillus para uso no tratamento e prevenção de infecção em animais aquáticos
CY1122191T1 (el) Βακτηριο για χρηση ως προβιοτικο για διατροφικες και ιατρικες εφαρμογες
MX2016006147A (es) Suplemento alimenticio.
MX2019014045A (es) Composiciones y metodos.
ECSP20084274A (es) Composiciones para animales, y sus usos
BR112013005426A2 (pt) "composto, composição, formulação farmacêutica, métodos para inibir uma enzima, para matar e/ou prevenir o crescimento de um micro-organismo, para tratar e/ou prevenir uma doença em um animal, e para inibir o domínio de edição de uma sintetase de t-rna, e, uso de um composto ou uma de combinação."
MX2016009898A (es) Tratamientos para acne resistente.
PH12017500708A1 (en) Probiotic and prebiotic compositions
NZ706636A (en) Probiotic and prebiotic compositions
CO2020012954A2 (es) Siloxanos biocompatibles para formulación de microorganismos
MX376210B (es) Uso de derivados de isoxazolina para el tratamiento o prevención de infestaciones por artrópodos en aves de corral.
PL3675886T3 (pl) Mieszanka probiotyczna bacillus i bakterii kwasu mlekowego do poprawy zdrowia zwierząt hodowlanych
MX2019007555A (es) Uso de bacterias de acido láctico para tratar o prevenir la diabetes mellitus gestacional.
WO2020139020A3 (ko) 헬리코박터 파일로리 연관 질환의 예방 또는 치료용 김치
MX2020010243A (es) Composiciones bucales y metodos para animales.
BR112016029889A2 (pt) uso de biomassa tratada hidrotermicamente como ligante de micotoxinas
BR112016016842A2 (pt) Composição compreendendo um herbicida seletivo e um extrato de algas, uso de um extrato de algas para desintoxicar plantas submetidas ao tratamento com um herbicida seletivo
BR112016029890A2 (pt) uso de biomassa tratada hidrotermicamente como ligante de patógeno
RU2011151224A (ru) Способ профилактики и лечения некробактериоза парнокопытных животных
RU2012136668A (ru) СПОСОБ ДЕЗИНВАЗИИ ЯИЦ СТРОНГИЛЯТ ЛОШАДЕЙ С ПРИМЕНЕНИЕМ ШТАММОВ БАКТЕРИЙ Bacillus subtilis THП-3, Bacillus subtilis THП-5
MX2021013177A (es) Metodos para mejorar el tratamiento del colico equino mediante la administracion de un bioensamblaje sintetico o cepas purificadas de este.
RU2011119844A (ru) Способ повышения качества яичной продукции кур
Vavilov Food quality pond carp at use diet selenium-containing preporat Selenolin
NZ752367A (en) Nitrogen utilisation modulation